Selenium and Thinking abnormal - a phase IV clinical study of FDA data

Summary:

Thinking abnormal is reported as a side effect among people who take Selenium (selenium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Biotin, and have Hair loss.

The phase IV clinical study analyzes which people have Thinking abnormal when taking Selenium. It is created by eHealthMe based on reports of 5,049 people who have side effects when taking Selenium from the FDA, and is updated regularly.

What is Selenium?

Selenium has active ingredients of selenium. It is often used in vitamin supplementation. eHealthMe is studying from 5,314 Selenium users. Check the latest studies of Selenium.

What is Thinking abnormal?

Thinking abnormal is found to be associated with 1,069 drugs and 1,182 conditions by eHealthMe. Check the latest studies of Thinking abnormal.

On Jun, 19, 2026

5,049 people reported to have side effects when taking Selenium.
Among them, 16 people (0.32%) have Thinking abnormal.

Among these 16 people:

How long have people been on Selenium when they have Thinking abnormal? *

What is the gender of people who have Thinking abnormal when taking Selenium? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Thinking abnormal when taking Selenium? *

What are other drugs people take besides Selenium? *

What are other side effects people have besides Thinking abnormal? *

Insomnia (sleeplessness): 11 people, 68.75%
Fall: 11 people, 68.75%
Feeling Abnormal: 10 people, 62.50%
Drug Ineffective: 10 people, 62.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 56.25%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 56.25%
Confusion: 9 people, 56.25%
Sleep Disorder: 9 people, 56.25%
Sleep Paralysis (waking up and unable to move or speak): 9 people, 56.25%
Hallucinations (sensations that appear real but are created by your mind): 9 people, 56.25%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 62.50%
Hair Loss: 10 people, 62.50%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 56.25%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 56.25%
Constipation: 8 people, 50.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 12.50%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 2 people, 12.50%
Diabetes: 2 people, 12.50%
Gait Disturbance: 2 people, 12.50%
Gout (uric acid crystals building up in the body): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Selenium and have Thinking abnormal?

- Check whether Thinking abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Selenium:

Selenium (5,314 reports)

Browse all side effects of Selenium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thinking abnormal:

Thinking abnormal (1,069 drugs)

Browse all the conditions that are associated with Thinking abnormal:

Thinking abnormal (1,182 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on selenium (the active ingredients of Selenium) and Selenium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.